Peg-interfon alpha-2a and low-dose ribavirin for treatment of hepatitis C virus infection in patients with sickle-cell anemia in Saudi Arabia

BACKGROUND AND OBJECTIVES: Data regarding the safety and efficacy of antiviral therapy with pegylated interferon (PEG-IFN) and ribavirin (RBV) in patients with sickle-cell disease (SCD) and hepatitis C virus (HCV) infection are scanty. In this study, our aim was to evaluate the safety and efficacy o...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Saudi Med
Prif Awduron: Agha, Adnan, Chakik, Rafaat, Abdulhadi Ali, Mamdouh M., Alsaudi, Dib, Sammito, Giorgio, Giannini, Edoardo Giovanni
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: King Faisal Specialist Hospital and Research Centre 2013
Pynciau:
Brief Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6074907/
https://ncbi.nlm.nih.gov/pubmed/24413867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5144/0256-4947.2013.610
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg